R&F Capital Advisors’s Chemours CC Stock Holding History

R&F Capital Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18,603	Closed	-$411K	–	692
2016 Q4	$411K	Buy	+18,603	New	+$382K	0.15%	221

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

R&F Capital Advisors's CC Position: Q1 2017 in Review

R&F Capital Advisors sold out of Chemours (CC) in Q1 2017, closing a stake of 18,603 shares — an estimated $411K sold.

R&F Capital Advisors first reported a position in CC in Q4 2016 and held it in 1 quarter. The position peaked at $411K in Q4 2016. 459 funds tracked by Wall St. Rank hold CC as of Q1 2017.

R&F Capital Advisors reported no remaining Chemours position as of Q1 2017 after selling out during the quarter.
R&F Capital Advisors sold 18,603 Chemours shares in Q1 2017, an estimated $411K.
R&F Capital Advisors first reported a position in Chemours in Q4 2016 and held it in 1 quarter.
R&F Capital Advisors's Chemours position peaked at $411K in Q4 2016.
459 funds tracked by Wall St. Rank held Chemours as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.